SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-21-001726
Filing Date
2021-10-15
Accepted
2021-10-15 16:03:32
Documents
4
Period of Report
2021-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e3191_8-k.htm 8-K 14786
2 e3191_contract.htm EX-99.9 CUST CONTRCT 66201
3 GRAPHIC img001.jpg GRAPHIC 5159
4 GRAPHIC img002.jpg GRAPHIC 6696
  Complete submission text file 0001731122-21-001726.txt   98868
Mailing Address 73-4460 QUEEN KA'AHUMANU HWY. SUITE 110 KAILUA-KONA HI 96740
Business Address 73-4460 QUEEN KA'AHUMANU HWY. SUITE 110 KAILUA-KONA HI 96740 954-648-2013
MERA PHARMACEUTICALS INC (Filer) CIK: 0000837490 (see all company filings)

IRS No.: 043683628 | State of Incorp.: DE | Fiscal Year End: 0615
Type: 8-K | Act: 34 | File No.: 033-23460 | Film No.: 211326081
SIC: 8731 Services-Commercial Physical & Biological Research